- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
TrovaGene Inc+ Add to Watchlist
TROV:US6.8500 USD 0.1600 2.39%
As of 20:10:00 ET on 05/20/2013.
Company Profile for TrovaGene Inc (TROV)
TrovaGene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.
Key Executives for TrovaGene Inc (TROV)
|Antonius P Schuh "Tony"Chief Executive Officer||Stephen L Zaniboni "Steve"Chief Financial Officer|
|Mark ErlanderChief Scientific Officer|